Items where Author is "Bunning, Rowena"
Number of items: 7.
SNUGGS, Joseph, DAY, Rebecca, BACH, Frances, CONNER, Matthew, BUNNING, Rowena, TRYFONIDOU, Marianna and LE MAITRE, Christine
(2019).
Aquaporin expression in the human and canine intervertebral disc during maturation and degeneration.
JOR spine, 2 (1), e1049.
[Article]
ABUNEEZA, Esadawi, CROSS, Alison, HADDOCK, Gail, BUNNING, Rowena and WOODROOFE, Nicola
(2014).
Expression of ADAMTS-9 in the central nervous system in multiple sclerosis and its relationship to cleavage of aggrecan and versican.
Journal of Neuroimmunology, 275 (1-2), 131-132.
[Article]
DUNN, Sara, WILKINSON, J.M., CRAWFORD, A., LE MAITRE, Christine and BUNNING, Rowena
(2014).
Cannabinoid WIN-55,212-2 mesylate inhibits interleukin-1β induced matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human chondrocytes.
Osteoarthritis and Cartilage, 22 (1), 133-144.
[Article]
WANG, Jianru, TIAN, Ye, PHILLIPS, Kate L. E., CHIVERTON, Neil, HADDOCK, Gail, BUNNING, Rowena, CROSS, Alison, SHAPIRO, Irving M., LE MAITRE, Christine and RISBUD, Makarand V.
(2013).
Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1.
Arthritis & rheumatism, 65 (3), 832-842.
[Article]
WANG, Jianru, TIAN, Ye, PHILLIPS, Kate L. E., CHIVERTON, Neil, HADDOCK, Gail, BUNNING, Rowena, CROSS, Alison, SHAPIRO, Irving M., LE MAITRE, Christine and RISBUD, Makarand V.
(2013).
Tumor necrosis factor α- and interleukin-1β-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1.
Arthritis & rheumatism, 65 (3), 832-842.
[Article]
TURNER, Sharon L., MANGNALL, David, BIRD, Nigel C., BUNNING, Rowena and BLAIR-ZAJDEL, Maria E.
(2012).
Expression of ADAMTS-1, ADAMTS-4, ADAMTS-5 and TIMP3 by hepatocellular carcinoma cell lines.
International Journal of Oncology, 41 (3), 1043-1049.
[Article]
HURST, Louise A., BUNNING, Rowena, SHARRACK, Basil and WOODROOFE, Nicola
(2012).
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Neuroscience Letters, 521, 52-56.
[Article]